Trial for reduction of anxiety and fatigue -open study
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000042928
- Lead Sponsor
- IMEQRD inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 20
Not provided
Subjects who 1.are currently receiving any types of medicines and/or Chinese medical treatment (except for the drugs taken as needed). 2.plan to change their lifestyle during the test. 3.have a serious illness such as liver, kidney, heart, respiratory tract, endocrine, metabolic disease, etc.. 4.are receiving treatment for mental illness such as depression or anxiety disorder, or have a history of it. 5.May take sleeping pills/ sleep-inducing drugs during the test period, continuously or when they need. 6.Have been diagnosed with chronic fatigue syndrome. 7.Have had life events that affect their mind and body such as loss of important things within one month (death of relatives, loss of employment, divorce, pet death). 8.Take healthy foods or supplements daily. (acceptable if they can stop taking after obtaining consent.) 9.have a past and current medical history of drug or food allergy. 10.have participated in other clinical trials within one month before obtaining consent, or those who plan to participate during the trial period. 11.consume alcohol excessively (alcohol equivalent 60g or more / day). 12.have smoking habit. 13.have an irregular diet, or irregular life rhythms (work in shifts, work late at night etc.). 14.are judged by the investigator to be unsuitable for participating in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method fatigue VAS score(anxiety fatigue) QOL questionnaire (behavior changes) Sleep questionnaire (SMH)
- Secondary Outcome Measures
Name Time Method